Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche image

Roche to launch new MS collaboration

June 23, 2014
Research and Development, Sales and Marketing MS, Roche, inception sciences, multiple sclerosis, versant ventures

Roche has launched a new research collaboration to investigate ways of reversing the debilitating nerve damage caused by multiple sclerosis …

News

Novartis back under microscope

June 23, 2014
Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines

Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …

News
screen_shot_2014-06-23_at_09

Life Sciences Hub Wales – new COO and
 board



June 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Hub Wales, Wales, ian barwick

Dr Ian Barwick has been appointed chief operating officer for Life Sciences Hub Wales along with several new board members.
  …

Appointment

£100 million funding stream aids UK biotech

June 23, 2014
Research and Development, Sales and Marketing BIA, Steve Bates, biomedical catalyst, funding

UK biotech companies are developing new therapies for cancer, Parkinson’s, diabetes and tinnitus as a direct result of the £100 …

News
LaMattina image

Drug prices defy gravity – until patent expiry

June 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research

How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …

Feature
dr_mark_hooper

Conversis Medical hires global director

June 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing conversis, hooper, medical

Medical translation agency Conversis Medical has appointed Dr Mark Hooper as its global director. Hooper has worked in the pharma …

Appointment
boehringer image

Boehringer abandons hep C

June 23, 2014
Research and Development, Sales and Marketing AbbVie, Boehringer, HCV, faldaprevir, german, hep C

Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …

News
Lilly image

Lilly’s Efient tipped for expanded NICE approval

June 20, 2014
Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner

 Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …

News
Dr Reddy's image

Dr Reddy’s recalls blood pressure drug

June 20, 2014
Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol

Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …

News
minas_maroudas__pan

PAN expands creative team with two hires

June 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ogilvy, Pan

Creative agency PAN has increased its team by hiring two new people in Minas Maroudas (pictured) who joins as senior …

Appointment
Cameron image

Dementia research ‘achingly slow’

June 20, 2014
Research and Development, Sales and Marketing Alzheimer's, Cameron, Parkinson's, Parkinsons, UK, billings, dementia, research

The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …

News
AbbVie logo

AbbVie moves in on Shire with $46 billion bid

June 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

News

Novartis emphasises pharma growth

June 19, 2014
Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory

Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …

News
Dr Phillip Frost image

Teva chairman stepping down amid revamp

June 19, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

News
Valeant image

Valeant goes hostile over Allergan hunt

June 19, 2014
Sales and Marketing Allergan, Botox, Valeant, hostile, takeover

Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …

News
Dementia image

£16m dementia research platform launched

June 19, 2014
Research and Development, Sales and Marketing Alzheimer's, MRC, Parkinson's, brain, dementia, ukdp

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …

News
dominique_pizzingrilli

Bartlett hires account manager

June 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dominique Pizzingrilli, bartlett Davis Communications

Bartlett Davis Communications has welcomed Dominique Pizzingrilli to the newly-created role of account manager. Pizzingrilli takes a wealth of healthcare …

Appointment
Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

News
Social media image

FDA publishes ‘new thinking’ on social media use

June 18, 2014
Medical Communications, Sales and Marketing ABPI, FDA, Facebook, Twitter, social media

The FDA has issued new draft guidance on how pharmaceutical and medical device firms in the US can talk about …

News

Genome-driven lung cancer trial launches

June 18, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer

Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026